A Phase I, Open-Label, Multi-Center, Single Dose, Dose-Escalating, Safety, Tolerability, and Pharmacokinetic Study of GC1008 in Patients with Idiopathic...
|Effective start/end date||9/29/06 → 12/31/08|
- GENZYME CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.